The long-term treatment of coronary artery disease (CAD) mainly involves medication. The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD.Load more
The long-term treatment of coronary artery disease (CAD) mainly involves medication. The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD.
In order to prevent the development of related conditions, all people with CAD are advised to take antiplatelets and statins. Beta-blockers are sometimes used as add-on therapy, particularly in people who have heart failure or hypertension.
Novel therapeutic strategies under investigation include such as stem cells, nanotechnology, robotic surgery and other advancements. These treatment modalities show promising effects in managing CAD and associated conditions. Research on stem cells focuses on studying the potential for cardiac regeneration, while nanotechnology investigates nano-drug delivery and percutaneous coronary interventions including stent modifications and coatings.Load Less
Sara C Martinez, Sharonne N HayesUS Cardiology Review 2016;10(1):14–20DOI: http://dx.doi.org/10.15420/usc.2016.10.1.14
Jacqueline SawInterventional Cardiology Review 2013;10(3):142–3DOI: https://doi.org/10.15420/icr.2015.10.03.142
John Rawlins, Jehangir Din, Suneel Talwar, et alInterventional Cardiology Review 2015;10(2):85–9DOI: https://doi.org/10.15420/icr.2015.10.2.85
Preventive Percutaneous Coronary Intervention in ST-elevation Myocardial Infarction – The Primacy of Randomised TrialsDavid S Wald, Jonathan P BestwickInterventional Cardiology Review 2015;10(1):32–4DOI: https://doi.org/10.15420/icr.2015.10.1.32